Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Cardio Diagnostics Holdings (CDIOW) Depreciation & Amortization (CF) (2023 - 2025)

Historic Depreciation & Amortization (CF) for Cardio Diagnostics Holdings (CDIOW) over the last 3 years, with Q3 2025 value amounting to $5655.0.

  • Cardio Diagnostics Holdings' Depreciation & Amortization (CF) rose 1776.34% to $5655.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $89232.0, marking a year-over-year increase of 47214.67%. This contributed to the annual value of $113777.0 for FY2024, which is 290203.17% up from last year.
  • Per Cardio Diagnostics Holdings' latest filing, its Depreciation & Amortization (CF) stood at $5655.0 for Q3 2025, which was up 1776.34% from $8485.0 recorded in Q2 2025.
  • In the past 5 years, Cardio Diagnostics Holdings' Depreciation & Amortization (CF) registered a high of $37656.0 during Q1 2025, and its lowest value of $1377.0 during Q3 2023.
  • Over the past 3 years, Cardio Diagnostics Holdings' median Depreciation & Amortization (CF) value was $4802.0 (recorded in 2024), while the average stood at $11800.6.
  • In the last 5 years, Cardio Diagnostics Holdings' Depreciation & Amortization (CF) surged by 145142.98% in 2024 and then skyrocketed by 1776.34% in 2025.
  • Over the past 3 years, Cardio Diagnostics Holdings' Depreciation & Amortization (CF) (Quarter) stood at $2413.0 in 2023, then surged by 1451.43% to $37436.0 in 2024, then plummeted by 84.89% to $5655.0 in 2025.
  • Its Depreciation & Amortization (CF) stands at $5655.0 for Q3 2025, versus $8485.0 for Q2 2025 and $37656.0 for Q1 2025.